Cipher Pharmaceuticals Stock Analysis
| CPH Stock | CAD 14.40 0.38 2.57% |
Cipher Pharmaceuticals has over 40.58 Million in debt which may indicate that it relies heavily on debt financing. With a high degree of financial leverage come high-interest payments, which usually reduce Cipher Pharmaceuticals' Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Cipher Pharmaceuticals' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Cipher Pharmaceuticals' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Cipher Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Cipher Pharmaceuticals' stakeholders.
For many companies, including Cipher Pharmaceuticals, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Cipher Pharmaceuticals, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Cipher Pharmaceuticals' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Cipher Pharmaceuticals' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Cipher Pharmaceuticals is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Cipher Pharmaceuticals to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Cipher Pharmaceuticals is said to be less leveraged. If creditors hold a majority of Cipher Pharmaceuticals' assets, the Company is said to be highly leveraged.
Cipher Pharmaceuticals is fairly valued with Real Value of 14.37 and Hype Value of 14.36. The main objective of Cipher Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Cipher Pharmaceuticals is worth, separate from its market price. There are two main types of Cipher Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Cipher Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Cipher Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Cipher Pharmaceuticals stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Cipher Pharmaceuticals is usually not traded on Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day. Cipher Stock trading window is adjusted to America/Toronto timezone.
Cipher |
Cipher Stock Analysis Notes
About 43.0% of the company shares are held by company insiders. The book value of Cipher Pharmaceuticals was currently reported as 6.14. The company had not issued any dividends in recent years. Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company was founded in 2000 and is headquartered in Oakville, Canada. CIPHER PHARMACEUTICALS operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs people. For more info on Cipher Pharmaceuticals please contact the company at 905 602 5840 or go to https://www.cipherpharma.com.Cipher Pharmaceuticals Investment Alerts
Cipher Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 365.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cipher Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Cipher Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Cipher Profitablity
Cipher Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Cipher Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Cipher Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cipher Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cipher Pharmaceuticals' profitability requires more research than a typical breakdown of Cipher Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.35 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.39 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.39. Technical Drivers
As of the 6th of February, Cipher Pharmaceuticals shows the Risk Adjusted Performance of 0.0559, downside deviation of 1.55, and Mean Deviation of 1.35. Cipher Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Cipher Pharmaceuticals Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
Cipher Pharmaceuticals Outstanding Bonds
Cipher Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cipher Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cipher bonds can be classified according to their maturity, which is the date when Cipher Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Cipher Pharmaceuticals Predictive Daily Indicators
Cipher Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cipher Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 468.78 | |||
| Daily Balance Of Power | (1.12) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 14.57 | |||
| Day Typical Price | 14.51 | |||
| Price Action Indicator | (0.36) | |||
| Period Momentum Indicator | (0.38) |
Cipher Pharmaceuticals Forecast Models
Cipher Pharmaceuticals' time-series forecasting models are one of many Cipher Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cipher Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Cipher Pharmaceuticals Debt to Cash Allocation
Cipher Pharmaceuticals has accumulated 40.58 M in total debt with debt to equity ratio (D/E) of 62.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Cipher Pharmaceuticals has a current ratio of 1.04, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Cipher Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Cipher Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cipher Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cipher to invest in growth at high rates of return. When we think about Cipher Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Cipher Pharmaceuticals Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Cipher Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Cipher Pharmaceuticals, which in turn will lower the firm's financial flexibility.Cipher Pharmaceuticals Corporate Bonds Issued
About Cipher Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cipher Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cipher shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cipher Pharmaceuticals. By using and applying Cipher Stock analysis, traders can create a robust methodology for identifying Cipher entry and exit points for their positions.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company was founded in 2000 and is headquartered in Oakville, Canada. CIPHER PHARMACEUTICALS operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cipher Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.